Evidence map›Paper›PMID 36560431›Full record

ArticleVaccines2022

Potential Novel N-Glycosylation Patterns Associated with the Emergence of New Genetic Variants of PRRSV-2 in the U.S.

Igor A D Paploski, Dennis N Makau, Nakarin Pamornchainavakul, Julia P Baker, Declan Schroeder, Albert Rovira, Kimberly VanderWaal

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Igor A D PaploskiDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108, USA.
Dennis N MakauDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108, USA.ORCID 0000-0002-1802-2545
Nakarin PamornchainavakulDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108, USA.ORCID 0000-0003-0378-0316
Julia P BakerDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108, USA.
Declan SchroederDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108, USA.ORCID 0000-0001-5991-2838
Albert RoviraDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108, USA.
Kimberly VanderWaalDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, MN 55108, USA.ORCID 0000-0002-5764-6430
University of Minnesota · US

Funding

Biotechnology and Biological Sciences Research Council BB/T004401/1
6 · The paper itself

Abstract

Glycosylation of proteins is a post-translational process where oligosaccharides are attached to proteins, potentially altering their folding, epitope availability, and immune recognition. In Porcine reproductive and respiratory syndrome virus-type 2 (PRRSV-2), positive selection pressure acts on amino acid sites potentially associated with immune escape through glycan shielding. Here, we describe the patterns of potential N-glycosylation sites over time and across different phylogenetic lineages of PRRSV-2 to better understand how these may contribute to patterns of coexistence and emergence of different lineages. We screened 19,179 PRRSV GP5 sequences (2004−2021) in silico for potential N-glycosylated sites. The emergence of novel combinations of N-glycosylated sites coincided with past PRRSV epidemics in the U.S. For lineage L1A, glycosylation at residues 32, 33, 44, 51, and 57 first appeared in 2012, but represented >62% of all L1A sequences by 2015, coinciding with the emergence of the L1A 1-7-4 strain that increased in prevalence from 8 to 86% of all L1A sequences from 2012 to 2015. The L1C 1-4-4 strain that emerged in 2020 also had a distinct N-glycosylation pattern (residues 32, 33, 44, and 51). From 2020 to 2021, this pattern was responsible for 44−47% of the L1C sequences, contrasting to <5% in years prior. Our findings support the hypothesis that antigenic evolution contributes to the sequential dominance of different PRRSV strains and that N-glycosylation patterns may partially account for antigenic differences amongst strains. Further studies on glycosylation and its effect on PRRSV GP5 folding are needed to further understand how glycosylation patterns shape PRRSV occurrence.

Indexed as

emergenceepidemiologyglycosylationmulti-strain dynamicsPRRSV

Identifiers

PMID36560431
PMCPMC9787953
OpenAlexW4310211379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.